a portfolio company of
has acquired
ABOUT THE COMPANY:
SITUATION:
ENGAGEMENT:
OUTCOME:
The acquisition of MDS was successfully executed in June 2020, building density in existing footprint, while also bringing SDS Rx into new geographies and providing access to a new healthcare end market. Furthermore, G2 has successfully sourced two targets in addition to MDS that are currently under LOI.
DEAL TEAM:
SUB-SECTOR
Healthcare Logistics
MORE LIKE THIS
Exclusive Buy-Side Advisor
a portfolio company of Gryphon Investors has acquired SuperLube the operating assets of Sysco
Exclusive Buy-Side Advisor
a portfolio company of Incline Equity Partners has acquired ChangeCX
Exclusive Buy-Side Advisor
a portfolio company of SilverMill, LLC and PNC Riverarch Capital Partners has acquired Lifecycle Biotechnologies, LP
Exclusive Buy-Side Advisor
Kelvin Group
a portfolio company of Southfield Capital has acquired Advanced Examination Services
Exclusive Buy-Side Advisor
a portfolio company of O2 Investment Partners has acquired LCS Facility Group
Exclusive Buy-Side Advisor
a portfolio company of Berkshire Partners has acquired Complete Fire Protection
Exclusive Buy-Side Advisor
a portfolio company of Alvarez & Marsal Capital has acquired Midwest Computech
Exclusive Buy-Side Advisor
a portfolio company of Court Square has acquired Asset Black